Literature DB >> 23054957

Idiopathic hypercalciuria and bone health.

Laura E Ryan1, Steven W Ing.   

Abstract

Calcium is an important participant in many physiologic processes including coagulation, cell membrane transfer, hormone release, neuromuscular activation, and myocardial contraction. The body cooperates in a sophisticated web of hormonally mediated interactions to maintain stable extracellular calcium levels. Calcium is vital for skeletal mineralization, and perturbations in extracellular calcium may be corrected at the expense of bone strength and integrity. The aim of this review is to delineate our current understanding of idiopathic hypercalciuria in the context of bone health, specifically its definition, etiology, epidemiology, laboratory evaluation, and potential therapeutic management.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23054957     DOI： 10.1007/s11914-012-0120-5

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN： 1544-1873            Impact factor:   5.096


  71 in total

1.  Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.

Authors:  John R Asplin; Kimberly A Bauer; Jennifer Kinder; Georg Müller; Brian J Coe; Joan H Parks; Fredric L Coe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

2.  Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine.

Authors:  B A LAMBERG; B KUHLBACK
Journal:  Scand J Clin Lab Invest       Date:  1959       Impact factor: 1.713

3.  The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin.

Authors:  A HODGKINSON; L N PYRAH
Journal:  Br J Surg       Date:  1958-07       Impact factor: 6.939

4.  Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism.

Authors:  N A Breslau; L Brinkley; K D Hill; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

5.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

6.  Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures.

Authors:  M R Sowers; M Jannausch; C Wood; S K Pope; L L Lachance; B Peterson
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

7.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

8.  Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

Authors:  A E Broadus; K L Insogna; R Lang; A F Ellison; B E Dreyer
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

9.  Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria.

Authors:  A Ghazali; V Fuentès; C Desaint; P Bataille; A Westeel; M Brazier; L Prin; A Fournier
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

10.  Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

Authors:  Charles Y Pak; Howard J Heller; Margaret S Pearle; Clarita V Odvina; John R Poindexter; Roy D Peterson
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450
View more
  8 in total

1.  The value of hypercalciuria in patients with osteopenia versus osteoporosis.

Authors:  María Sierra Girón-Prieto; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Salvador Arias-Santiago; Tomás de Haro-Muñoz; Miguel Arrabal-Martín; Miguel Ángel Arrabal-Polo
Journal:  Urolithiasis       Date:  2016-08-01       Impact factor: 3.436

2.  The importance of urinary calcium in postmenopausal women with osteoporotic fracture.

Authors:  Miguel Angel Ochoa-Hortal Rull; María Del Carmen Cano-García; Miguel Arrabal-Martín; Miguel Angel Arrabal-Polo
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

3.  The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.

Authors:  Miguel Arrabal-Martin; Antonio Poyatos-Andujar; María del Carmen Cano-García; Miguel Quesada-Charneco; Felix Abad-Menor; María Sierra Girón Prieto; Tomás de Haro Muñoz; Miguel Angel Arrabal-Polo
Journal:  Int Urol Nephrol       Date:  2015-02-05       Impact factor: 2.370

4.  Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; Marc Grynpas; Amy VandenEynde; John R Asplin; Kevin K Frick; Min Ho Kim; Felix M Ramos; Ignacio Granja; David A Bushinsky
Journal:  Nephron       Date:  2019-02-06       Impact factor: 2.847

Review 5.  Osteoporosis in men: recent progress.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

6.  Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.

Authors:  María Sierra Girón-Prieto; Salvador Arias-Santiago; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Tomás de Haro-Muñoz; Felix Abad-Menor; Miguel Quesada-Charneco; Miguel Ángel Arrabal-Polo; Miguel Arrabal-Martín
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

7.  Hypercalciuria in Postmenopausal Women With Reduced Bone Mineral Density Is Associated With Different Mineral Metabolic Profiles: Effects of Treatment With Thiazides and Anti-resorptives.

Authors:  Federico Nicoli; Giorgia Dito; Gregorio Guabello; Matteo Longhi; Sabrina Corbetta
Journal:  Front Med (Lausanne)       Date:  2021-12-15

8.  Urinary calcium excretion in postmenopausal African American women.

Authors:  John F Aloia; Albert Shieh; Mageda Mikhail; Shahidul Islam
Journal:  Clin Nephrol       Date:  2015-09       Impact factor: 0.975
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.